METTL3 could accelerate the protein levels of SOX2, CD133, and CD44 to maintain or promote BC cell stemness, which was triggered by the m6A modification of SOX2 mRNA by METTL3, ultimately leading to the alteration in enhanced BC invasion and migration capabilities (Xie et al., 2021). Here, PROM1 is linked to breast cancer.